Cooper Companies (The) (COO)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: OPHTHALMIC GOODS

6101 BOLLINGER CANYON ROAD SAN RAMON, CA 94583

The Cooper Companies, Inc. (Cooper) is a global medical products company that serves the specialty healthcare market through its two business units, CooperVision, Inc. (CVI) and CooperSurgical, Inc. (CSI). CVI develops, manufactures and markets a range of contact lenses for the global vision correction market. CVI specializes in lenses for astigmati® presbyopia and ocular dryness. CVI is a manufacturer of toric lenses, which correct astigmati® multifocal lenses for presbyopia (blurring near vision due to advancing age) and spherical lenses that correct the common visual defects. CVIs products are manufactured at its facilities located in the United Kingdom, Puerto Rico and New York. CVI distributes products from Rochester, New York, Fareham, the United Kingdom, Liege, Belgium, and smaller international distribution facilities.

Data as of 2020-09-12
Market Cap17.026 Billion Shares Outstanding53.34 Million Avg 30-day Volume321.415 Thousand
P/E Ratio58.1 Dividend Yield0.019 EPS5.59
Price/Sales6.975 Price cash flow ratio34.4 Price free cash flow ratio108.9
Book Value70.49 Price to Tangible Book4678.39 Alpha0.0
Short Interest Ratio2.65 % Short Interest to Float1.4 R-squared0.336423
BETA0.889471 52-week High/Low365.68 / 236.675 Stddev0.065524
View SEC Filings from COO instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 3 -100.0% 0 (0.0%) 1 (0.06%) -100.0%
Funds Holding: 488 477 2.31% 96 (6.26%) 92 (5.88%) 4.35%
13F shares: 47.4 Million 46.985 Million 0.88% 8.109 Million 8.697 Million -6.76%
% Ownership 88.8751 88.1022 0.88% 15.2045 16.3073 -6.76%
New Positions: 65 45 44.44% 21 12 75.0%
Increased Positions 176 177 -0.56% 21 34 -38.24%
Closed Positions 46 63 -26.98% 14 20 -30.0%
Reduced Positions 185 188 -1.6% 45 36 25.0%
Total Calls 84.585 Thousand 67.967 Thousand 24.45% 23.9 Thousand 22.1 Thousand 8.14%
Total Puts 203.884 Thousand 151.429 Thousand 34.64% 49.775 Thousand 34 Thousand 46.4%
PUT/CALL Ratio 2.41 2.23 8.07% 2.08 1.54 35.06%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding COO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding COO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

6.5 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

6.5 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LINDELL JODY S

18,804 2020-09-16 4

MCBRIDE DANIEL G EVP, COO & PRES-COOPERVISION

34,173 2020-09-11 4

WHITE ALBERT G III PRESIDENT & CEO

41,430 2020-07-08 4

SHEFFIELD HOLLY R EVP, CSO

2,699 2020-07-08 5

RICUPATI AGOSTINO SVP, FIN & TAX; CHIEF ACTG OFF

1,964 2020-07-01 5

PETERSMEYER GARY S

1,338 2020-05-29 3

BENDER A THOMAS

18,618 2020-04-01 1

KALKSTEIN MICHAEL

5,838 2020-04-01 3

RUBENSTEIN ALLAN E

3,191 2020-04-01 1

WEISS ROBERT S

142,081 2020-04-01 3

JAY COLLEEN

3,658 2020-04-01 1

KOZY WILLIAM A

3,928 2020-04-01 1

DRURY MARK J VP, GENERAL COUNSEL & SEC.

760 2020-02-15 1

ANDREWS BRIAN G SVP, CFO & TREASURER

2,958 2020-02-03 3

GOLDEN RANDAL VP, GENERAL COUNSEL & SEC.

1,673 2020-02-03 3

AUERBACH ROBERT D PRESIDENT, CSI

3,916 2020-02-03 3

ZINBERG STANLEY MD

  • Director
10,528 2019-03-11 0

KAUFMAN CAROL R EVP, SEC. & CHIEF GOV. OFFICER

  • Officer
45,898 2018-04-11 0

REMMELL PAUL L PRES & CEO - COOPERSURGICAL

  • Officer
1,352 2017-07-14 0

MALONEY TINA VP, CORPORATE CONTROLLER

  • Officer
2,874 2017-01-08 0

MATZ GREGORY W SVP, CFO & CRO

  • Officer
15,123 2016-06-13 0

ROSENBERG STEVEN

  • Director
12,359 2016-01-05 0

PICHOTTA NICHOLAS J PRES, CEO COOPER MEDICAL, INC.

  • Officer
10,697 2014-01-08 0

FOLDEN RODNEY VP & CORPORATE CONTROLLER

  • Officer
8,592 2014-01-08 0

WEBER JOHN ARTHUR PRESIDENT, COOPERVISION, INC.

  • Officer
15,260 2014-01-08 0

PRESS DONALD

  • Director
43,970 2014-01-07 0

MIDLOCK EUGENE J VP TAX

  • Officer
12,959 2012-01-09 0

MARX MOSES

  • Director
107,532 2009-12-01 0

SEDGWICK ANDREW PRESIDENT, EMEA

  • Officer
0 2009-09-30 0

MURPHY DENNIS PRESIDENT AMERICAS, CVI

  • Officer
0 2009-09-11 0

MCLEAN JEFFREY ALAN EXEC VP, COMM. STRATEGIES-CVI

  • Officer
0 2008-12-10 0

FRUTH JOHN D

  • Director
6,500 2008-01-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

LINDELL JODY S matthews-lindell family trust dated july 23 1991 as amended and restated

2020-09-17 17:21:22 -0400 2020-09-16 S 6,500 $338.69 d 12,554 indirect -1.3192 -3.8074 0.0 1 -5.0227 5

LINDELL JODY S matthews-lindell family trust dated july 23, 1991 as amended and restated

2020-09-17 17:21:22 -0400 2020-09-16 M 6,500 $66.80 a 19,054 indirect -1.3192 -3.8074 0.0 1 -5.0227 5

LINDELL JODY S matthews-lindell family trust, dated july 23, 1991 as amended and restated

2020-09-17 17:21:22 -0400 2020-09-16 M 6,500 d 0 indirect

MCBRIDE DANIEL G EVP, COO & PRES-COOPERVISION

2020-09-11 18:42:56 -0400 2020-09-11 G 300 d 32,053 direct 0.4514 2.185 3.9546 4 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments